Preclinical evidence demonstrates that genetic or pharmacological downregulation of overexpressed SOD in colorectal and nasopharyngeal cancer models promotes tumor cell apoptosis, suppresses migratory capacity, and inhibits metastatic seeding [329]. Here, SOD1 is linked to neoplasm.